======= KLF5 ======= == Gene Information == * **Official Symbol**: KLF5 * **Official Name**: Kruppel like factor 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=688|688]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13887|Q13887]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KLF5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KLF5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602903|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor that binds to GC box promoter elements. Activates the transcription of these genes. |zf-C2H2| |satellite cell activation involved in skeletal muscle regeneration| |cell-cell signaling via exosome| |positive regulation of transcription by transcription factor localization| |skeletal muscle satellite cell activation| |MRF binding| |skeletal muscle satellite cell differentiation| |regulation of microvillus assembly| |myotube differentiation involved in skeletal muscle regeneration| |intestinal epithelial cell development| |regulation of microvillus organization| |microvillus assembly| |microvillus organization| |intestinal epithelial cell differentiation| |positive regulation of pri-miRNA transcription by RNA polymerase II| |skeletal muscle tissue regeneration| |regulation of pri-miRNA transcription by RNA polymerase II| |columnar/cuboidal epithelial cell development| |skeletal muscle cell differentiation| |myotube differentiation| |positive regulation of fat cell differentiation| |tissue regeneration| |columnar/cuboidal epithelial cell differentiation| |response to leukemia inhibitory factor| |cellular response to leukemia inhibitory factor| |regulation of fat cell differentiation| |skeletal muscle tissue development| |digestive tract development| |skeletal muscle organ development| |digestive system development| |regeneration| |epithelial cell development| |regulation of plasma membrane bounded cell projection assembly| |striated muscle cell differentiation| |regulation of cell projection assembly| |transcription factor complex| |muscle cell differentiation| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |angiogenesis| |cellular response to peptide| |developmental growth| |growth| |blood vessel morphogenesis| |plasma membrane bounded cell projection assembly| |DNA-binding transcription activator activity, RNA polymerase II-specific| |cell projection assembly| |response to peptide| |muscle structure development| |wound healing| |transcription by RNA polymerase II| |blood vessel development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |cellular response to organic cyclic compound| |response to wounding| |cellular response to organonitrogen compound| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |tube morphogenesis| |cellular response to nitrogen compound| |epithelial cell differentiation| |intracellular membrane-bounded organelle| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |tube development| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |positive regulation of cell population proliferation| |response to organic cyclic compound| |regulation of cellular component biogenesis| |positive regulation of cell differentiation| |Golgi apparatus| |response to organonitrogen compound| |cellular response to cytokine stimulus| |cellular response to oxygen-containing compound| |cell activation| |response to nitrogen compound| |nucleobase-containing compound biosynthetic process| |response to cytokine| |epithelium development| |cell-cell signaling| |plasma membrane bounded cell projection organization| |cell projection organization| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular protein localization| |cellular macromolecule localization| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp142|OICR-9429 10μM R03 exp142]]|-1.75| ^Gene^Correlation^ |[[:human genes:r:ruvbl2|RUVBL2]]|0.414| Global Fraction of Cell Lines Where Essential: 52/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|3/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|5/17| |esophagus|2/13| |fibroblast|0/1| |gastric|5/16| |kidney|0/21| |liver|1/20| |lung|5/75| |lymphocyte|0/16| |ovary|4/26| |pancreas|5/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|5/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17090 * **Expression level (log2 read counts)**: 1.78 {{:chemogenomics:nalm6 dist.png?nolink |}}